Progen Biotechnik GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Progen Biotechnik GmbH - overview
Location
Heidelberg, -, Germany
Primary Industry
Biotechnology
About
Progen develops, produces and markets tests for patient glucose testing, infectious diseases and products for biomedical research.
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.progen.de
Verticals
HealthTech
Total Amount Raised
Subscriber access only
Progen Biotechnik GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Progen Biotechnik GmbH | - | ||||||||
| Unspecified Exit | Completed | Progen Biotechnik GmbH | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.